MAJA SCHAPPELL: Open Payments
NPI 1912500307 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 12 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $586 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LEQVIO, Kerendia, ONPATTRO, REPATHA, MOUNJARO, NEXLETOL, FARXIGA.
Industry payments across NY — which companies pay providers there.
